The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1305
ISSUE1305
February 9, 2009
Two New Drugs for Chronic ITP
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Two New Drugs for Chronic ITP
February 9, 2009 (Issue: 1305)
Romiplostim (Nplate - Amgen), a recombinant fusion protein injected subcutaneously, and eltrombopag (Promacta - GlaxoSmithKline), a non-peptide taken orally, have been approved by the FDA for treatment of chronic immune thrombocytopenic purpura (ITP)...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.